Journal Article (Letter)

DZNE-2026-00538

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png A Clinician View of the EMA Explanation of the Approval of Amyloid-Targeting Therapies

Jessen, F. (First author)DZNE* ; Fortea, J.

2026
Elsevier [Amsterdam]

This record in other databases:  

Please use a persistent id in citations: doi:10.1016/j.lanepe.2026.101708

---

Contributing Institute(s):

1. Clinical Alzheimer’s Disease Research (AG Jessen)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2026

---

Database coverage:
; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Social and Behavioral Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 20 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Social Sciences Citation Index ; Web of Science Core Collection

---